Why is World Pharmaceutical Frontiers essential reading?
The pharmaceutical industry is changing faster than ever before. Regulations are becoming more demanding, and there are more technologies, faster product launches and shorter product life cycles. At the same time the cost of R&D is continuously increasing. This is putting heavier financial pressure on pharma to reduce costs and shorten lead times without compromising quality or patient safety, and choosing the right investment has never been more essential.
World Pharmaceutical Frontiers is the premier information source for the world's leading pharmaceutical companies, with reliable and accurate intelligence on emerging trends and breakthrough technologies to help them make critical business decisions.
Focusing on all areas of the pharmaceutical industry and aimed at senior executives in charge of purchasing, R&D and manufacturing, World Pharmaceutical Frontiers provides a clear overview of the latest industry thinking regarding pharma and is essential reading for those who want to stay ahead of the competition.
The cost of bringing a new drug to market is staggering. Major pharmaceutical companies now invest between $4 billion and $12 billion in developing each new product.
Containing expenditure in this area is a key issue; however, the cost of clinical trials continues to rise due to the increased complexity of studies. This means that making an informed decision when choosing the right partner has never been more critical.
Clinical Trials Insight provides a unique platform for information-sharing and best practice for primary decision-makers engaged in the process of managing all aspects of clinical trials. This hard-to-reach community of executives is actively occupied with purchasing the products and services needed to bring new drugs to market.
Compelling content is at the heart of Clinical Trials Insight and is provided by a combination of industry leaders and practitioners, along with key analysts and commentators.
Published in print and digital formats, this multi-platform publication is a valuable and effective way of reaching and influencing a high-spending community of industry leaders.